Roth Capital Initiates Coverage On OS Therapies with Buy Rating, Announces Price Target of $7
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsInitiationPrice Target
Roth Capital analyst Adam Walsh initiates coverage on OS Therapies (AMEX:OSTX) with a Buy rating and announces Price Target of $7.
Roth Capital analyst Adam Walsh initiates coverage on OS Therapies (AMEX:OSTX) with a Buy rating and announces Price Target of $7.